Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Alzheimer's & dementia (Amsterdam, Netherlands)
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Masaya KumamotoDepartment of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Toshiharu NinomiyaDepartment of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Yoshihiko FurutaDepartment of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Mao ShibataDepartment of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Tomoyuki OharaDepartment of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Jun HataCenter for Cohort Studies Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Tetsuro AgoDepartment of Medicine and Clinical Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Yasuyuki TakiDepartment of Aging Research and Geriatric Medicine Institute of Development Aging and Cancer Tohoku University Sendai Japan.
Tatsuya MikamiDepartment of Preemptive Medicine Innovation Center for Health Promotion Graduate School of Medicine Hirosaki University Aomori Japan.
Tetsuya MaedaDivision of Neurology and Gerontology Department of Internal Medicine School of Medicine Iwate Medical University Yahaba Japan.
Kenjiro OnoDepartment of Neurology Kanazawa University Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.
Masaru MimuraDepartment of Neuropsychiatry Keio University School of Medicine Tokyo Japan.
Ritsuko HanajimaDivision of Neurology Department of Brain and Neurosciences Faculty of Medicine Tottori University Yonago Japan.
Jun-Ichi IgaDepartment of Neuropsychiatry Ehime University Graduate School of Medicine Ehime University Toon Japan.
Minoru TakebayashiDepartment of Psychiatry and Neuroscience Center for Metabolic Regulation of Healthy Aging Faculty of Life Sciences Kumamoto University Kumamoto Japan.
Yukihide MomozawaLaboratory for Genotyping Development RIKEN Center for Integrative Medical Sciences Yokohama Japan.
Japan Prospective Studies for Aging and Dementia (JPSC‐AD) Study Group#
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
introductionApolipoprotein E (
methodsThis cross-sectional study included 9605 community-dwelling Japanese individuals aged ≥65 years.
resultsThe odds ratio (OR) for dementia increased with the number of DISCUSSION: Favorable risk factor profiles were associated with lower dementia risk and preserved brain structure in
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.